Kole, I. H., Vural, P., Yurdacan, B., Alemdar, A., & Mutlu, C. (2024). Evaluation of SLC6A2 and CYP2D6 polymorphisms’ effects on atomoxetine treatment in attention deficit and hyperactivity disorder. European Journal of Clinical Pharmacology, 80(11), 1773-1785. https://doi.org/10.1007/s00228-024-03744-z
Chicago-referens (17:e uppl.)Kole, Ismail Hasan, Pınar Vural, Beste Yurdacan, Adem Alemdar, och Caner Mutlu. "Evaluation of SLC6A2 and CYP2D6 Polymorphisms’ Effects on Atomoxetine Treatment in Attention Deficit and Hyperactivity Disorder." European Journal of Clinical Pharmacology 80, no. 11 (2024): 1773-1785. https://doi.org/10.1007/s00228-024-03744-z.
MLA-referens (9:e uppl.)Kole, Ismail Hasan, et al. "Evaluation of SLC6A2 and CYP2D6 Polymorphisms’ Effects on Atomoxetine Treatment in Attention Deficit and Hyperactivity Disorder." European Journal of Clinical Pharmacology, vol. 80, no. 11, 2024, pp. 1773-1785, https://doi.org/10.1007/s00228-024-03744-z.
